“…1 Reports have shown that the visual loss from HCQ toxicity is less likely to be reversible once fundus changes are present. [1][2][3] Although newer testing modalities, such as spectral domain-optical coherence tomography, fundus autofluorescenece, and multifocal electroretinogram, are now recommended as part of screening when available, 2 automated perimetry remains the most readily available screening test in the majority of practices. Additionally, eye care providers are familiar with interpretation of HVF for glaucoma and other conditions.…”